PXN confers intrinsic TKI resistance in EGFR-mutated NSCLC cells.6 The IC50 value for gefitinib in six EGFR-mutated NSCLC cell lines was evaluated by the MTT assay. This evidence concerns the gene EGFR and non-small cell lung carcinoma.